Followers | 1321 |
Posts | 26906 |
Boards Moderated | 6 |
Alias Born | 12/10/2012 |
Friday, December 30, 2022 9:14:18 AM
Stop at $13
LETS GOOOOOOOOOOOOOOOOOOOOOOOoooooooooooooooooooooooooooooooo
GO $DISC
Recent IRON News
- Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/06/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:49:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:39:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:38:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:36:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 01:43:00 PM
- Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer • GlobeNewswire Inc. • 02/26/2024 01:30:00 PM
- Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 09:22:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 11:51:49 PM
- Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera • GlobeNewswire Inc. • 02/09/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:55 PM
- Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:55:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/23/2024 10:48:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/04/2024 09:24:27 PM
- Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 10:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:18:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2024 09:30:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:15:06 PM
- Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board • GlobeNewswire Inc. • 12/20/2023 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:15:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2023 09:19:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM